These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6781810)

  • 1. Mechanism of valproate-phenobarbital interaction in epileptic patients.
    Kapetanović IM; Kupferberg HJ; Porter RJ; Theodore W; Schulman E; Penry JK
    Clin Pharmacol Ther; 1981 Apr; 29(4):480-6. PubMed ID: 6781810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenobarbital--valporic acid interaction.
    Patel IH; Levy RH; Cutler RE
    Clin Pharmacol Ther; 1980 Apr; 27(4):515-21. PubMed ID: 6766833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of valproate on the metabolism of phenobarbital in the rat.
    Anderson GD; Levy RH
    Pharm Res; 1992 Dec; 9(12):1622-8. PubMed ID: 1488407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of sodium valproate on phenobarbital serum levels in children and adults.
    Fernandez de Gatta MR; Alonso Gonzalez AC; Garcia Sanchez MJ; Dominguez-Gil Hurle A; Santos Borbujo J; Monzon Corral L
    Ther Drug Monit; 1986; 8(4):416-20. PubMed ID: 3103264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of phenobarbital and sodium valproate in treating convulsive epilepsy in rural northeast China.
    Li J; Yang D; Zhao D; Li N; Lin W
    Seizure; 2019 Oct; 71():207-213. PubMed ID: 31394367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of phenobarbitone N-glucosidation by valproate.
    Bernus I; Dickinson RG; Hooper WD; Eadie MJ
    Br J Clin Pharmacol; 1994 Nov; 38(5):411-6. PubMed ID: 7893581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sodium valproate: pharmacokinetics and effectivensss in treating intractable seizures.
    Redenbaugh JE; Sato S; Penry JK; Dreifuss FE; Kupferberg HJ
    Neurology; 1980 Jan; 30(1):1-6. PubMed ID: 6985719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Steady-state valproate pharmacokinetics during long term therapy.
    Eadie MJ; Heazlewood V; McKauge L; Tyrer JH
    Clin Exp Neurol; 1983; 19():183-91. PubMed ID: 6439443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stable isotope methodology and gas chromatography mass spectrometry in a pharmacokinetic study of phenobarbital.
    Kapetanović IM; Kupferberg HJ
    Biomed Mass Spectrom; 1980 Feb; 7(2):47-52. PubMed ID: 7407331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Double-blind study on the anti-convulsive effect of phenobarbital and valproate in the Lennox syndrome].
    Vassella F; Rüdeberg A; Da Silva V; Pavlincova E
    Schweiz Med Wochenschr; 1978 May; 108(19):713-6. PubMed ID: 347569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valproic acid in childhood epilepsy: anticonvulsive efficacy in relation to its plasma levels.
    Klotz U; Schweizer C
    Int J Clin Pharmacol Ther Toxicol; 1980 Oct; 18(10):461-5. PubMed ID: 6782028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isobolographic analysis of interactions between remacemide and conventional antiepileptic drugs in the mouse model of maximal electroshock.
    Borowicz KK; Malek R; Luszczki JJ; Ratnaraj N; Patsalos PN; Czuczwar SJ
    Epilepsy Behav; 2007 Aug; 11(1):6-12. PubMed ID: 17602881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Certain aspects of interaction between sodium valproate and other anticonvulsant drugs in the therapy of epilepsy in children.
    Sobaniec W
    Mater Med Pol; 1992; 24(2):115-9. PubMed ID: 1307765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of clobazam with conventional antiepileptics in children.
    Theis JG; Koren G; Daneman R; Sherwin AL; Menzano E; Cortez M; Hwang P
    J Child Neurol; 1997 Apr; 12(3):208-13. PubMed ID: 9130097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Valproic acid and plasma levels of phenobarbital.
    Bruni J; Wilder BJ; Perchalski RJ; Hammond EJ; Villarreal HJ
    Neurology; 1980 Jan; 30(1):94-7. PubMed ID: 6985722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of pharmacokinetic interactions between steady-state zonisamide and valproic acid in patients with epilepsy.
    Ragueneau-Majlessi I; Levy RH; Brodie M; Smith D; Shah J; Grundy JS
    Clin Pharmacokinet; 2005; 44(5):517-23. PubMed ID: 15871637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brivaracetam population pharmacokinetics in children with epilepsy aged 1 month to 16 years.
    Schoemaker R; Wade JR; Stockis A
    Eur J Clin Pharmacol; 2017 Jun; 73(6):727-733. PubMed ID: 28280887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Antiepileptic drugs on plasma lipoprotein (a) and other lipid levels in childhood.
    Aynaci FM; Orhan F; Orem A; Yildirmis S; Gedik Y
    J Child Neurol; 2001 May; 16(5):367-9. PubMed ID: 11392523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonlinear mixed effects modelling approach in investigating phenobarbital pharmacokinetic interactions in epileptic patients.
    Vučićević K; Jovanović M; Golubović B; Kovačević SV; Miljković B; Martinović Ž; Prostran M
    Eur J Clin Pharmacol; 2015 Feb; 71(2):183-90. PubMed ID: 25380628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Valproic acid in the treatment of epilepsy with special emphasis on serum level determination (author's transl)].
    Fröscher W; Schulz HU; Gugler R
    Fortschr Neurol Psychiatr Grenzgeb; 1978 Jun; 46(6):327-41. PubMed ID: 352872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.